Related Experiment Video
Updated: Jun 29, 2026
08:48
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
Integrins in breast cancer dormancy
Stephanie M Pontier1, William J Muller
1Department of Biochemistry, Faculty of Medicine, McGill University, Montreal, Canada.
Summary
Breast cancer recurrence is common, with 20-45% of patients developing new lesions after treatment. Recent research highlights integrin proteins as key regulators of dormant cancer cell survival and eventual relapse.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- A significant percentage of breast cancer patients (20-45%) experience disease recurrence after initial treatment.
- Recurrence can manifest after extended remission periods, sometimes spanning decades, suggesting a dormant cancer cell phenotype.
- The molecular mechanisms underlying this long-term dormancy and subsequent reactivation of breast cancer cells are not fully understood.
Purpose of the Study:
- To explore the molecular underpinnings of dormant breast cancer cell survival.
- To investigate the role of specific proteins in regulating the long-term dormancy and reactivation of malignant breast cells.
- To synthesize recent findings on the involvement of integrins in breast cancer relapse.
Main Methods:
- Review of scientific literature published within the last 10 years.
- Analysis of clinical observations regarding breast cancer recurrence patterns.
- Focus on molecular events associated with dormant phenotypes and integrin protein function.
Main Results:
- Clinical data indicate that breast cancer cells can remain dormant for extended periods before proliferating.
- Recent research points to integrin proteins playing a crucial role in regulating this dormant state.
- Integrins are implicated in the survival and potential reactivation of subclinically surviving malignant cells.
Conclusions:
- Integrin proteins are critical regulators of breast cancer cell dormancy and subsequent relapse.
- Understanding integrin function may offer new therapeutic targets to prevent long-term recurrence.
- Further research into the molecular pathways involving integrins is warranted to combat breast cancer persistence.
Related Concept Videos
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...